Dermatology
Dermatology
Advertisement
Katie KoskoChronic Spontaneous Urticaria | January 14, 2025
Biologic therapies for the treatment of chronic spontaneous urticaria (CSU) are potentially underutilized in veterans.
Read More
Tamara ThomasUrban Health Weekly | December 27, 2024
Alisha Bridges Talks Patient Advocacy and Plaque & Scalp Psoriasis on Skin of Color
Rebecca AraujoChronic Spontaneous Urticaria | December 16, 2024
Around 70% of patients presenting to the emergency department for urticaria received diphenhydramine.
Rob DillardEczema | December 16, 2024
A study described the global, regional, and national atopic dermatitis prevalence trends among children from 2000-2021.
Tamara ThomasUrban Health Weekly | December 14, 2024
Dr. Amy McMichael Discusses Plaque Psoriasis on Skin of Color, Johnson & Johnson's VISIBLE Study.
Rob DillardEczema | December 10, 2024
Early-onset atopic dermatitis (AD) is associated with higher rates of developing atopic March conditions.
Rob DillardEczema | December 5, 2024
Racial and ethnic disparities negatively impact access to treatment for Black and Hispanic children with atopic dermatitis.
Rebecca AraujoChronic Spontaneous Urticaria | November 26, 2024
The Urticaria Activity Score is commonly utilized in chronic spontaneous urticaria clinical trials.
Rebecca AraujoChronic Spontaneous Urticaria | November 14, 2024
Acupuncture therapy as an adjunct to omalizumab was found to improve disease control and quality of life.
Urban Health Today EditorsPsoriasis | November 6, 2024
Patient advocate and influencer Alisha Bridges talks about living with Plaque & Scalp Psoriasis as a person of color.
Rebecca AraujoChronic Spontaneous Urticaria | October 31, 2024
Patients with CSU who utilized a digital telehealth platform reported improved quality-of-life scores.
Urban Health Today EditorsPsoriasis | October 22, 2024
Dr. Amy McMichael discusses plaque psoriasis on skin of color and Johnson & Johnson's VISIBLE study.
Cailin ConnerChronic Spontaneous Urticaria | October 15, 2024
Urticaria raises the risk of ADHD, bipolar disorder, and schizophrenia.
Rebecca AraujoAllergy | October 4, 2024
Dupilumab is a monoclonal antibody approved to treat atopic dermatitis in adolescents and children.
Cailin ConnerChronic Spontaneous Urticaria | October 3, 2024
Omalizumab is a safe and effective long-term treatment for CSU.
Rebecca AraujoAllergy | September 19, 2024
Most respondents agreed a patient-centered definition would improve communication with providers.
Cailin ConnerChronic Spontaneous Urticaria | September 18, 2024
Nearly 50% of patients with chronic spontaneous urticaria are atopic, with atopy linked to increased risk of dermatographism,
Cailin ConnerChronic Spontaneous Urticaria | September 17, 2024
A recent study demonstrated significant associations between acute urticaria and cardiovascular comorbidities.
Cailin ConnerChronic Spontaneous Urticaria | September 18, 2024
Autoimmune mast cell activation test shows promise as a diagnostic tool for chronic spontaneous urticaria.
Rebecca AraujoAllergy | September 17, 2024
The global prevalence of pediatric atopic dermatitis increased from 1990 to 2019.
Advertisement
Advertisement
Advertisement
Latest News

February 14, 2025